Post-stroke cognitive impairment and dementia

NS Rost, A Brodtmann, MP Pase, SJ van Veluw… - Circulation …, 2022 - Am Heart Assoc
Poststroke cognitive impairment and dementia (PSCID) is a major source of morbidity and
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …

Low‐field MRI: clinical promise and challenges

TC Arnold, CW Freeman, B Litt… - Journal of Magnetic …, 2023 - Wiley Online Library
Modern MRI scanners have trended toward higher field strengths to maximize signal and
resolution while minimizing scan time. However, high‐field devices remain expensive to …

[HTML][HTML] Dementia epidemiology fact sheet 2022

JH Shin - Annals of Rehabilitation Medicine, 2022 - synapse.koreamed.org
This dementia epidemiology fact sheet 2022 is aimed at providing an overview of the
epidemiology of dementia in Korea using representative government-led data. This review …

[HTML][HTML] Vascular cognitive impairment (VCI)

T Rundek, M Tolea, T Ariko, EA Fagerli, CJ Camargo - Neurotherapeutics, 2023 - Elsevier
Vascular cognitive impairment (VCI) is predominately caused by vascular risk factors and
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …

The prevalence of dementia: a systematic review and meta-analysis

Q Cao, CC Tan, W Xu, H Hu, XP Cao… - Journal of …, 2020 - content.iospress.com
Dementia is a severe neurodegenerative disorder and it can be categorized into several
subtypes by different pathogenic causes. We sought to comprehensively analyzed the …

[HTML][HTML] Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

L Jia, Y Du, L Chu, Z Zhang, F Li, D Lyu, Y Li… - The Lancet public …, 2020 - thelancet.com
Background China has a large population of older people, but has not yet undertaken a
comprehensive study on the prevalence, risk factors, and management of both dementia …

Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases

D Furtado, M Björnmalm, S Ayton, AI Bush… - Advanced …, 2018 - Wiley Online Library
Therapies directed toward the central nervous system remain difficult to translate into
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …

[HTML][HTML] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive …

C Cicognola, S Janelidze, J Hertze… - Alzheimer's research & …, 2021 - Springer
Introduction Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …

Molecular biomarkers for vascular cognitive impairment and dementia

S Hosoki, GK Hansra, T Jayasena, A Poljak… - Nature Reviews …, 2023 - nature.com
As disease-specific interventions for dementia are being developed, the ability to identify the
underlying pathology and dementia subtypes is increasingly important. Vascular cognitive …

Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta‐analysis

DKY Leung, WC Chan, A Spector… - International journal of …, 2021 - Wiley Online Library
Objective The present study aimed to resolve inconsistency in reported prevalence of
affective symptoms by dementia stage. Methods/Design We conducted a meta‐analysis of …